SCHEMBL1935331

SCHEMBL1935331

CCCSc1cccc(N)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.47
MAOA P21397 2/20 0.44
MAOB P27338 1/20 0.44
TSHR P16473 1/20 0.43
CYP3A4 P08684 3/20 0.42
CASP1 P29466 3/20 0.42
RECQL P46063 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA13 Q8N1Q1 1/20 0.42
TP53 P04637 2/20 0.41
CRBN Q96SW2 1/20 0.40
BACE1 P56817 1/20 0.40
AR P10275 2/20 0.39
ALDH1A1 P00352 4/20 0.38
MAPK1 P28482 1/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL424970 0.89 TSHR (0.49) MAPTMAOAMAOBTSHRCYP3A4
SCHEMBL11833630 0.85 TSHR (0.54) MAPTMAOAMAOBTSHRALDH1A1
SCHEMBL13397723 0.85 MAOA (0.47) MAPTMAOAMAOBCA12CA1
SCHEMBL926391 0.83 CYP3A4 (0.46) MAPTMAOAMAOBTSHRCYP3A4
SCHEMBL30426786 0.83 CYP3A4 (0.46) MAPTMAOAMAOBTSHRCYP3A4
Hydrochloric Acid SCHEMBL2651523 0.82 CYP3A4 (0.44) MAPTMAOAMAOBTSHRCYP3A4
SCHEMBL16943335 0.80 BACE1 (0.43) MAPTMAOAMAOBTSHRCYP3A4
SCHEMBL4424118 0.80 BACE1 (0.43) MAPTMAOAMAOBTSHRCYP3A4
SCHEMBL7354068 0.80 CRBN (0.43) MAOAMAOBCYP3A4CASP1RECQL
SCHEMBL14666370 0.78 MEN1 (0.42) MAPTMAOAMAOBCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103172571-A New preparation method of insect repellent albendazole CHANGZHOU YABANG QH PHARMACHEM CO LTD 2013-06-26 CN claimed
US-9493480-B2 Monomeric trioxane amide sulfur compounds THE JOHNS HOPKINS UNIVERSITY (US) 2016-11-15 US disclosed
US-20150183798-A1 MONOMERIC TRIOXANE AMIDE SULFUR COMPOUNDS THE JOHNS HOPKINS UNIVERSITY (US) 2015-07-02 US disclosed
CN-103172571-A New preparation method of insect repellent albendazole CHANGZHOU YABANG QH PHARMACHEM CO LTD 2013-06-26 CN disclosed
WO-2012142575-A2 MONOMERIC TRIOXANE AMIDE SULFUR COMPOUNDS THE JOHNS HOPKINS UNIVERSITY (US) 2012-10-18 WO disclosed
US-20110245284-A1 Alkoxy- and Alkylthio-Substituted Anilinopyrimidines BAYER CROPSCIENCE AG (DE) 2011-10-06 US disclosed
EP-2331512-A1 ALKOXY-SUBSTITUTED AND ALKYLTHIO-SUBSTITUTED ANILINOPYRIMIDINES Bayer CropScience AG (DE) 2011-06-15 EP disclosed
WO-2010025833-A1 ALKOXY-SUBSTITUTED AND ALKYLTHIO-SUBSTITUTED ANILINOPYRIMIDINES BAYER CROPSCIENCE AG (DE) 2010-03-11 WO disclosed
US-7291645-B2 Phenylalanine derivatives as alpha 4 integrin inhibitors ELAN PHARMACEUTICALS, INC. (US) 2007-11-06 US disclosed
US-7015216-B2 Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors ELAN PHARMACEUTICALS, INC. (US) 2006-03-21 US disclosed
US-6677339-B2 S-3-(4-(3,5-DICHLOROPYRID-4-YLCARBOXAMIDO)PHENYL)-2-(4,6-DIMET HOXY-1,3,5-TRIAZIN-2-YLAMINO)PROPANOIC ACID FOR EXAMPLE; INHIBIT BINDING OF ALPHA 4 INTEGRINS TO THEIR LIGANDS, FOR TREATING IMMUNE OR INFLAMMATORY DISORDERS CELLTECH R & D LIMITED (GB) 2004-01-13 US disclosed
US-20020086882-A1 Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors BIOGEN IDEC INTERNATIONAL HOLDING LTD. (BM) 2002-07-04 US disclosed
US-20020055509-A1 Phenylalanine derivatives as alpha 4 integrin inhibitors BIOGEN IDEC INTERNATIONAL HOLDING LTD. (BM) 2002-05-09 US disclosed
US-20020028812-A1 Phenylalanine derivatives CELLTECH CHIROSCIENCE LIMITED (GB) 2002-03-07 US disclosed
US-6348463-B1 Phenylalanine derivatives CELLTECH THERAPEUTICS LIMITED (GB) 2002-02-19 US disclosed
WO-2002008222-A2 HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS ELAN PHARMACEUTICALS, INC. (US) 2002-01-31 WO disclosed
WO-2002008206-A1 3-AMINO-2-(4-AMINOCARBONYLOXY)PHENYL-PROPIONIC ACID DERIVATIVES AS ALPHA-4- INTEGRIN INHIBITORS ELAN PHARMACEUTICALS, INC. (US) 2002-01-31 WO disclosed
EP-1117657-A1 PHENYLALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 2001-07-25 EP disclosed
WO-2000018759-A1 PHENYLALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 2000-04-06 WO disclosed
US-3958974-A Herbicidal N-aryl substituted azetidinones VELSICOL CHEMICAL CORPORATION (US) 1976-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020055509-A1 Phenylalanine derivatives as alpha 4 integrin inhibitors ITGB4, ITGA4, ITGB3 MAPT 2614/4885MAOA 1213/4885MAOB 720/4885
US-20020086882-A1 Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors ITGAL, ITGB4, ITGA4 MAPT 4015/4885MAOA 2539/4885MAOB 2860/4885
US-20020028812-A1 Phenylalanine derivatives PAH, FPR1, VCAM1 MAPT 2071/4885MAOA 437/4885MAOB 342/4885
US-20110245284-A1 Alkoxy- and Alkylthio-Substituted Anilinopyrimidines HAX1, AGPS, PYM1 MAPT 1978/4885MAOA 1371/4885MAOB 1427/4885
US-20150183798-A1 MONOMERIC TRIOXANE AMIDE SULFUR COMPOUNDS AS3MT, SQOR, TST MAPT 3041/4885MAOA 4432/4885MAOB 4196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.